Design Cross-sectional study. 
Introduction
Overactive bladder (OAB) is initially diagnosed based only on symptoms, without recourse to tests of urodynamic functions. It comprises symptoms of urinary urgency (a prerequisite for the diagnosis), urinary frequency (daytime and nighttime) with or without urge incontinence. According to the International Continence Society (ICS) year 2002 terminology, 1 localised conditions such as bladder tumours, bladder calculi, and urinary tract infections must first be ruled out. Moreover, OAB, especially with incontinence, is reported to have a significant influence on quality of life (QOL).
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The prevalence of OAB based on ICS definitions has varied in different epidemiological studies. According to the US Census Bureau international database, worldwide OAB prevalence in 2008 was 10.7% and is expected to reach to 20.1% by 2018. 4 Especially in Asia, it is expected to increase markedly (to 24.4% by 2018). 4 According to the World Population Ageing 2009 published by the United Nations, those aged 60 years or above in Hong Kong accounted for 17.7%, the median population age in 2009 being 41.4 years. 5 By 2050, at least half of Hong Kong population will be aged 55 years or above and have the highest mean age in the world. With these predictions, in the near future the number of patients with OAB will increase substantially in Hong Kong. 
膀胱過度活動症症狀評分表（中文版）的 信度和效度
Questionnaire, and the Primary OAB Symptom Questionnaire. The reproducibility of these tools have been investigated, 6, 7 but none are employed as a patient-reported outcome (PRO) measure for symptoms and QOL. Moreover, these instruments mainly focus on the effects of OAB on daily living and not on OAB symptoms. An Overactive Bladder Symptom Composite Score (OAB-SCS), on the other hand, can quantitatively evaluate OAB symptoms through the Indevus Urgency Severity Scale, which evaluates all voiding symptoms and urgency incontinences. 8 However, the OAB-SCS is a tedious and difficult instrument for patients to administer as it involves a micturition diary.
The Overactive Bladder Symptom Score questionnaire (OABSS) was originally developed by Homma et al 9 in 2006 to evaluate OAB symptoms. The questionnaire was developed in Japanese. Unlike other questionnaires measuring OAB, the OABSS makes evaluation of relevant symptoms possible as a single index. An OABSS total score is the sum of scores of several items-namely: daytime frequency, nighttime frequency, urgency, and urgency incontinence-the OABSS is, therefore, regarded as a PRO measure (one-stop test) without the need to complete a 3-day micturition diary. Moreover, the OABSS has been shown to have high sensitivity for treatment-related changes in OAB symptoms among Japanese patients. 10 To turn the original OABSS into Hong Kong Chinese (HKC), the key element was not only dependent on an accurate linguistic translation but also required a conceptual and cultural equivalence. A widely accepted international standard for translation and cultural adaptation (TCA) of PRO measures is the Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes Measures.
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The primary objective of this study was to evaluate the test-retest reliability of the HKC version of the OABSS (OABSS-HKC). The secondary objective was to validate the OABSS-HKC by evaluating its correlation with the existing standard OAB evaluation measures, namely: the 3-day micturition diary, International Prostate Symptom Scores (IPSS) and its QOL score, and the PPBC.
Methods

Translation and cultural adaptation process
The developer of the OABSS was contacted and permitted the authors to turn the OABSS Japanese version (source) into a HKC version. The source was translated and culturally adapted into the HKC version in accordance with the Principles of Good Practice for TCA Process for PRO Measures. 11 The TCA process included the following steps: for discrepancies. Dr Homma was consulted and resolved the difficult issues. The HKC translation was revised accordingly and the secondreconciled HKC version was produced. 6. A urologist, two other clinicians, and one urology nurse reviewed and fine-tuned the version into the third-reconciled HKC version. 7. Cognitive debriefing-the third-reconciled HKC version was self-administered by Chinesespeaking patients with OAB to assess their level of comprehension and cognitive equivalence of the translation. Before the cognitive debriefing study, ethics approval was obtained for conduct of the study. All patients who participated were asked to provide written informed consent prior to enrolment. 8. The cognitive debriefing results were reviewed and the translation was modified into the fourthreconciled HKC version. 9. After proofreading on spelling and formatting of the translation, a final OBASS-HKC was developed.
The validation process
A validation study of the final OABSS-HKC was conducted in five urology clinics of different regional hospitals serving an estimated population of 5 million in Hong Kong between October 2009 and February 2011. Male or female patients aged 18 years or older, with symptoms of OAB for at least 3 months and more than one episode of urinary urgency with or without urgency incontinence in the prior 3 days, were eligible to be screened in the study clinics. Patients were excluded if they predominantly had stress incontinence (as determined by the investigator), an indwelling catheter or were practising intermittent self-catheterization, a symptomatic urinary tract infection or chronic inflammation, had started an OAB treatment that was stopped or changed in the last 4 weeks, or had diabetic neuropathy. Written informed consent was obtained from patients prior to screening.
At screening, the investigators instructed the patients on how to record information on the micturition diary for 3 days prior to visit 1 (week 0) and visit 2 (week 2). The diary recorded the number of micturitions, and episodes of urgency, incontinence, nocturia, as well as volume of each void and number of incontinence pads used for 3 days prior to each visit. Recording for 1 day started when patients woke up and ended on the following day when the patient woke up.
At visit 1, the diary was assessed by the investigator for confirmation of patient eligibility. Patients had to have at least eight micturitions per day and at least one urgency episode as per record in the diary. Patients who did not complete the 3-day micturition diary according to instructions were excluded at visit 1. Eligible patients were asked to complete the second 3-day micturition diary over 3 days prior to visit 2. At both visits, patients completed the questionnaires, namely: the OABSS-HKC, IPSS and IPSS-QOL, and the PPBC.
During the study, indwelling catheters and intermittent self-catheterization were prohibited. Initiation of medications (namely, anticholinergics/ antispasmodics, anti-Parkinson drugs), α-antagonists, and tricyclic antidepressants (namely, amitriptyline and imipramine) were not allowed. Patients were not allowed to change dosages of any concomitant medications, namely, antidepressants (tri-and tetracyclic), antihistamines or antimetics, loop diuretics, neuroleptics, type I antiarrhythmics, and opioids.
Ethics approval was granted for the conduct of the study at each site. The study was conducted in accordance with International Conference on Harmonisation Good Clinical Practice guidelines and Declaration of Helsinki.
A sample size was calculated in order to archive an accuracy of parameter estimate, namely OABSS-HKC total score. Forty evaluable subjects were found to be required. In consideration of possible exclusions or dropout rates, the study planned to recruit up to 80 subjects. Descriptive statistics were calculated to summarise the demographic and clinical characteristics of patients. All statistical tests were two-tailed with a significance level of 0.05. Test-retest reliability was examined by calculating the intraclass correlation coefficient (ICC) for the OABSS-HKC total score, and weighted Kappa coefficients for each individual symptom score. Spearman's correlation coefficients were calculated to assess the degree of association between the OABSS-HKC total score and individual variables recorded in the 3-day micturition diary, the IPSS total score, and scores for IPSS-QOL and PPBC at visits 1 and 2. A correlation coefficient of 0.1 was considered small, 0.3 was moderate, and ≥0.5 was large, following the guidelines proposed by Cohen.
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Results
The translation and cultural adaptation process
During the TCA process, only minimal cultural and conceptual difficulties were encountered. The difficulties were resolved and conceptual equivalence in translations was reached by going through the reconciliations. In the cognitive debriefing, five patients with OAB symptoms administered the third-reconciled OABSS-HKC. The patients were interviewed by the study team about their views on the questionnaire. All the patients considered that the overall relevance and clarity of the questionnaire was moderate or high. They all found the length of the questionnaire acceptable and no unclear or irrelevant item in the questionnaire. The patients had no comments on the content of the questionnaire except that two of them found the presentation of the scoring system at the bottom of the table unclear, and suggested presenting the scoring system in a table format. The presentation of the scoring system was then modified. The reconciled translations were adjusted and the final OABSS-HKC was developed ( Table 1 ).
The validation study
Disposition and background characteristics of patients
Sixty-five patients were enrolled from a pool of approximately 900 new cases with OAB symptoms in approximately 15 months. Fourteen patients were excluded from the study (two were ineligible for screening, five had not completed the first 3-day micturition dairy, and seven the second micturition dairy). There were no significant differences in patient demographics and clinical characteristics between the 14 excluded patients and the remaining 51 patients.
The remaining patients in the study included 30 (59%) males and 21 (41%) females. Among them, 47 (92%) patients had at least three or more urgency episodes with or without incontinence at baseline assessment. Patient demographic and clinical characteristics are summarised in Table 2 As shown in Table 3 , the ICC indicated a fairto-strong association between answers to each of the variables in the standard measures at visits 1 and 2.
Construct validity study
Construct validity was evaluated using the OABSS-HKC total score and the variables in the standard measures ( Table 4 ). The OABSS-HKC total score correlated strongly with the number of incontinence episodes at visit 1 (r=0.406; P<0.05) and visit 2 (r=0.576; P<0.001) recorded in the diary and PPBC score at visit 1 (r=0.516; P<0.001) and visit 2 (r=0.499; P<0.001). The correlation was moderate to high for the number of micturition and urgency episodes recorded in the diary and the IPSS total score and QOL. The correlations were low for the number of nocturia episodes, voided volumes, and number of pads used.
Discussion
The OABSS developed by Homma et al in 2006 9 has been translated into various languages around the world, and widely employed for its utility. However, there are always reservations about a questionnaire developed by and for differing ethnic groups. This is because the symptoms and complaints expressed with a functional disorder such as OAB can vary with differing dispositions, such as social circumstances and regions, patient gender, age, individual conditions, or environments. Thus, the OABSS-HKC version was translated and culturally adapted in accordance with international guidelines. With the translated and culturally adapted OABSS-HKC, the study was conducted to evaluate whether or not the Japanese-developed OABSS was also valid for Hong Kong Chinese-speaking patients.
The test-retest reliability was high for the OABSS-HKC total score and each of the four constituents after a 2-week interval. The OABSS-HKC total score was correlated with the number of micturition, incontinence and urgency episodes recorded in the 3-day micturition diary, and other measures namely: the scores for IPSS, IPSS-QOL, and PPBC. The results suggest that the OABSS-HKC is a reliable and moderately valid PRO measure for OAB symptoms. The OABSS-HKC can be an alternative to the micturition diary for OAB symptom assessment in case patients or caregivers who are not capable in managing a micturition diary.
One limitation of the study was that the patients' answers to the OABSS-HKC may have been influenced by what the patients recorded in the micturition diaries in the previous 3 days. We believe such influence was minimised because all the patients were asked to record the requested events on the diary when they occurred (real-time recording) during those 3 days. At the study visits, all patients were asked to recall the events that occurred in the past 1 week and not just the past 3 days and record the answers in the OABSS-HKC. The patients were not allowed to read out from the diary while filling in the OABSS-HKC. Another limitation of the study was that the weights (scale of score) given to the individual items could influence the strength of associations with items in the micturition diary.
Notably, the nocturia episodes, total urine voided volumes, and number of pads used recorded in the diary were not significantly associated with the OABSS-HKC total score. This may be explained by the kind of pads used in this study not being standardised; a strong personal preference was The IPSS total score in this study showed significant correlations with OABSS-HKC total score, and concerns elements of voiding dysfunction and bladder storage symptoms. While it was established as a questionnaire to evaluate benign prostate hyperplasia (BPH) symptoms, the relevant signs and symptoms are similar to those of OAB patients. To date, it is the best available scoring tool used in clinical practice for OAB. The IPSS total score and various markers are used to evaluate the potency of BPH drugs, and the OABSS total scores are sometimes used simultaneously and are reported to yield similar outcomes. 13, 14 Notably, there was a strongly significant correlation between the OABSS-HKC total score and PPBC, which was similar to the findings of Homma and Gotoh. 15 In another recent report by Homma et al, 10 there was high correlation between OABSS total scores and 3-day micturition diary items, that were reported to yield high sensitivity for detecting OAB changes following treatment. In general, such findings are also in agreement with the results of this study and those report by Xu et al. 16 Another definite limitation of the current OABSS-HKC validation study was that the responsiveness to treatment was not evaluated, but further studies to look into this are planned.
Patients with OAB are often classified as incontinent (OAB wet) or without incontinence (OAB dry). Patients with incontinence obviously have lower QOLs than those without. In the report by Homma et al, 9 the OABSS total score distributions clearly differed in the two groups. Future studies in OAB patients need to use this classification.
Conclusions
The OABSS-HKC total score has high reproducibility and correlated with most of the variables in the micturition diary, the IPSS, and the PPBC. The OABSS-HKC total score is reliable and moderately valid for quantitative evaluation of OAB symptoms of Hong Kong Chinese-speaking patients.
